Literature DB >> 6849138

Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain.

R Schwarcz, W O Whetsell, R M Mangano.   

Abstract

A current hypothesis links the neuroexcitatory properties of certain acidic amino acids to their ability to cause selective neuronal lesions. Intracerebral injection of the neuroexcitatory tryptophan metabolite, quinolinic acid, has behavioral, neurochemical, and neuropathological consequences reminiscent of those of exogenous excitotoxins, such as kainic and ibotenic acids. Its qualities as a neurotoxic agent suggest that quinolinic acid should be considered as a possible pathogenic factor in neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849138     DOI: 10.1126/science.6849138

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  212 in total

1.  Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Authors:  P H Reddy; V Charles; M Williams; G Miller; W O Whetsell; D A Tagle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD): a structural and mechanistic unveiling.

Authors:  Lu Huo; Fange Liu; Hiroaki Iwaki; Tingfeng Li; Yoshie Hasegawa; Aimin Liu
Journal:  Proteins       Date:  2014-11-21

3.  The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease.

Authors:  Susanna Campesan; Edward W Green; Carlo Breda; Korrapati V Sathyasaikumar; Paul J Muchowski; Robert Schwarcz; Charalambos P Kyriacou; Flaviano Giorgini
Journal:  Curr Biol       Date:  2011-06-07       Impact factor: 10.834

Review 4.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

5.  Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis.

Authors:  Patricia A Zunszain; Christoph Anacker; Annamaria Cattaneo; Shanas Choudhury; Ksenia Musaelyan; Aye Mu Myint; Sandrine Thuret; Jack Price; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2011-11-09       Impact factor: 7.853

6.  Observing 3-hydroxyanthranilate-3,4-dioxygenase in action through a crystalline lens.

Authors:  Yifan Wang; Kathy Fange Liu; Yu Yang; Ian Davis; Aimin Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-30       Impact factor: 11.205

Review 7.  Therapy development in Huntington disease: From current strategies to emerging opportunities.

Authors:  Audrey S Dickey; Albert R La Spada
Journal:  Am J Med Genet A       Date:  2017-12-08       Impact factor: 2.802

8.  Comparative studies on dicholesteroyl diselenide and diphenyl diselenide as antioxidant agents and their effect on the activities of Na+/K+ ATPase and delta-aminolevulinic acid dehydratase in the rat brain.

Authors:  Ige J Kade; Marcio W Paixão; Oscar E D Rodrigues; Nilda B V Barbosa; Antonio L Braga; Daiana S Avila; Cristina W Nogueira; João B T Rocha
Journal:  Neurochem Res       Date:  2007-08-21       Impact factor: 3.996

Review 9.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

10.  Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease.

Authors:  N R Swerdlow; J Paulsen; D L Braff; N Butters; M A Geyer; M R Swenson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.